Rockefeller University

News, insights, analysis and data

Rockefeller University overview

Rockefeller University contact information

Offices

marker icon1230 York Avenue, New York, 10065, United States
Showing 1 of 1 Rockefeller University offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Jun Yang
Job titleChief Investment Officer and Vice President for Investments
LocationNew York, United States
Emaillock image-------
user imageMr. Romayne L. Botti
Job titleVice President for Finance and Chief Financial Officer
LocationNew York, United States
Emaillock image----------
user imageMr. Beth Krumholtz
Job titleAssociate Controller
LocationNew York, United States
Emaillock image------
user imageMr. Michael P. Vitale
Job titleController
LocationNew York, United States
Emaillock image------

Rockefeller University fund commitments

Known fund commitments: 14

FundManagerCommitment dateCommitment size
Managerlock image----------
Commitment date-
Commitment size-
Managerlock image------
Commitment date-
Commitment sizelock image-----------
Managerlock image--------
Commitment date-
Commitment sizelock image-------

Stories that mention Rockefeller University

Apollo prepares for fundraising slowdown as Epstein review gets underway

The firm expects some investors to pause new commitments as the board’s conflicts committee conducts an independent review into co-founder Leon Black’s relationship with Jeffrey Epstein.

Mayfield adds partner from IndieBio to expand into more engineering biology deals

Mayfield will also invest alongside IndieBio in their San Francisco batches every six months, as it cements its with the accelerator operator SOSV.

Life sciences investor SOSV looks for start-ups focused on covid-19 solutions

SOSV's labs, which have remained open during the national lockdown, have already worked with more than a dozen start-ups on the front lines of the covid-19 response.

Cerevance raises another $5 mln

The Dementia Discovery Fund, which is managed by SV Life Sciences, has invested $5 million in the initial financing round of Cerevance. Cerevance, a drug discovery company with offices in Boston and Cambridge, U.K., has raised $36 million in commitments of equity and non-dilutive capital from Lightstone Ventures and Takeda Pharmaceuticals Co Ltd.

Horbach named Co-Head of Carlyle US Buyout

Carlyle Group said July 28 that Allan M. Holt was named Chairman of US Buyout and Chairman of the Investment Committee for Carlyle’s US Buyout funds. Holt, a Managing Director, was previously co-head of the US Buyout team. Sandra J. Horbach, formerly Head of the Consumer & Retail team and an MD, is joining existing Co-head Peter J. Clare to lead Carlyle’s US Buyout business. Jay W. Sammons, a senior member of the Consumer & Retail team and an MD, succeeds Ms. Horbach.

NYU Stern receives $1.8 mln gift from Marie-Josée and Henry R. Kravis Foundation

The Marie-Josée and Henry R. Kravis Foundation have provided a $1.8 million gift to New York University Stern School of Business. The gift will establish The Marie-Josée and Henry R. Kravis Family Scholarship to support high-achieving, low-income students who are admitted to Stern’s Undergraduate College for Fall 2016. Recipients will be known as The Marie-Josée and Henry R. Kravis Scholars.

Intellia Therapeutics collects $15 mln

Intellia Therapeutics has received $15 million in Series A financing. Atlas Venture and Novartis led the round. Intellia develops therapeutic products for gene editing and repair.

Accelerator Corp raises $51.1 mln for fourth fund

Accelerator Corp. said Tuesday that it has raised $51.1 million in the first close of its fourth fund. The pool's investors include Alexandria Venture Investments, ARCH Venture Partners, WRF Capital, Eli Lilly, Harris & Harris Group, Johnson & Johnson Development Corp., The Partnership Fund for New York City and Pfizer Venture Investments. Based in Seattle and New York City, Accelerator Corp is a biotech investment firm.